We chose five trials providing mortality data for the following comparators: salmeterol, fluticasone, salmeterol fluticasone combination (SFC) or placebo.
"Provided that the further work demonstrates that the value for money case for GoCo over ENDPB/SP is conclusive, this will be followed by an investment appraisal that will test the GoCo against a public sector comparator, following which a decision on whether or not to proceed will be taken".
The purpose of this study was to address the following Population, Intervention, Comparator, Outcome, Timing, Study design and setting question: in patients with preoperative pain who undergo initial orthograde endodontic treatment, what is the comparative efficacy of NSAIDS compared with non-narcotic analgesics or placebo in reducing postoperative pain and the incidence of adverse events.
The number of spores following treatment with comparator drugs increased to the same level as the no-drug control treatment.
The following Patients Interventions Comparators Outcomes Studies (PICOS) criteria were followed for this search P: Patients with clinically significant BRVO or CRVO.
In contrast to the waning antibody titers seen in the rabies vaccine comparator group following the end of the malaria season, immunization with both the half dose and full dose of the malaria vaccine was followed by significant elevations in anti-AMA-1 antibodies.
2 10 The minimum data requirements for TES following placebo- and active comparator RCTs should be the same (93% agreement).
This was not done for comparators, again following a conservative approach, since risk reductions for this specific population were either not reported or lower than that in the overall population (Table 1).
A structured RQ about therapy should contain the following five elements: population, intervention, comparator, outcome, and time-frame.
To describe the time trend of the comparator arms, the following parameters, if available, were analysed at baseline: accrual year range, number of enrolled patients, percentage of patients with nephrectomy, risk score according to Memorial Sloan-Kettering criteriaenter (MSKCC) criteriandnd sites of metastases of potential prognostic relevance (the lung, liver, bone).
